Lansoprazole
- Product NDC
- 42291-364
- 11-digit product format
- 422910364
- Labeler code
- 42291
- Product ID
- 42291-364_d57afcb4-2922-fdd8-e053-2995a90a91f4
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Lansoprazole
- Dosage form
- CAPSULE, DELAYED RELEASE
- Route
- ORAL
- Labeler
- AvKARE
- Application
- ANDA077255
- Marketing category
- ANDA
- Marketing start
- 2013-08-05
- Marketing end
- 0000-00-00
- Substance
- LANSOPRAZOLE
- Active strength
- 15 mg/1
- Pharmacologic classes
- Proton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA],Inhibition Gastric Acid Secretion [PE]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 42291-364-01 | 42291036401 | 100 CAPSULE, DELAYED RELEASE in 1 BOTTLE (42291-364-01) | 2013-08-05 | 0000-00-00 | No | No | Current |
| 42291-364-30 | 42291036430 | 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (42291-364-30) | 2013-08-05 | 0000-00-00 | No | No | Current |